Go to:
Logótipo
Você está em: Start » Publications » View » Measles antibodies in cord blood in Portugal: Possible consequences for the recommended age of vaccination
Publication

Measles antibodies in cord blood in Portugal: Possible consequences for the recommended age of vaccination

Title
Measles antibodies in cord blood in Portugal: Possible consequences for the recommended age of vaccination
Type
Article in International Scientific Journal
Year
2016
Authors
Goncalves, G
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Nunes, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Mesquita, JR
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Frade, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: VaccineImported from Authenticus Search for Journal Publications
Vol. 34
Pages: 2750-2757
ISSN: 0264-410X
Publisher: Elsevier
Indexing
Other information
Authenticus ID: P-00K-E6J
Abstract (EN): The optimum age to give the first dose of measles vaccine must balance the risks of disease and vaccine failure. Both are influenced by the levels of transplacentally acquired maternal antibodies. This study was conducted in the Obstetric service of Portuguese hospital, in 2012-2013. Mothers were recruited after informed consent. Measles IgG was measured in 206 cord sera, using a commercial immunoassay. Geometric mean concentrations (and 95% CI) were 1849 mIU/ml (1196-2857) and 790 mIU/ml (618-1008) in cord sera of newborns from unvaccinated and vaccinated mothers respectively. Maternal age and vaccination status were both associated with the concentration in cord sera, but maternal age was the major predictor. The likely explanation is the same already mentioned in other studies: as a vaccination program progresses, vaccination coverage increases as measles incidence decreases. That results newborns from younger vaccinated mothers having less measles antibodies while the older mothers are more likely to have been infected with the wild virus. As the proportion of vaccinated mothers increase, developed countries tend to anticipate the recommended age of the first dose to 12 months of age. Models using hypothetical measles antibody decay rates in infancy were explored. Anticipating the first dose of MMR1 in Portugal to the age of 12 months might have not been the best decision but results were not conclusive, and arguments supporting or not the anticipation were discussed.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 8
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Rubella antibodies in cord blood sera in Portugal: association with maternal age and vaccination status (2018)
Article in International Scientific Journal
Frade, J; Nunes, C; Mesquita, JR; Nascimento, MSJ; Goncalves, G

Of the same journal

Susceptibility to tetanus and missed vaccination opportunities in Portuguese women (1999)
Article in International Scientific Journal
Goncalves, G; Santos, MA; Cutts, FT; Barros H
Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal (2015)
Article in International Scientific Journal
Gonçalves, G; Frade, J; Nunes, C; Mesquita, JR; Nascimento, MSJ
Mucosal immunization confers long-term protection against intragastrically established Neospora caninum infection (2016)
Article in International Scientific Journal
Ferreirinha, P; Alexandra Correia; Teixeira Coelho, M; Osorio, H; Teixeira, L; Rocha, A; Manuel Vilanova

See all (17)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Medicina da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2024-11-06 at 14:42:19
Acceptable Use Policy | Data Protection Policy | Complaint Portal | Política de Captação e Difusão da Imagem Pessoal em Suporte Digital